“Severe Immune-Related Cutaneous Vasculitis Induced by Osimertinib” (2022) Archives of Clinical and Medical Case Reports, 6(4), pp. 524–527. Available at: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22639 (Accessed: 12 November 2026).